LBCTR2020043495尚未招募3 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care - SOLIDARITY
WHO0 个研究点目标入组 1,000 人开始时间: 2020年11月4日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 至 99（—）
- 性别
- All
入选标准
- •Eligibility: consenting adults (age =18) hospitalised with definite COVID-19, not already receiving any of the study drugs, without known allergy or contra-indications to any of them (in the view of the physician responsible for their care), and without anticipated transfer within 72 hours to a non-study hospital. Patients invited to join the study will be those who are admitted to a collaborating hospital; no wider recruitment efforts are expected.
排除标准
- •Exclusion from study entry: Patients will not be randomised if, in the view of the randomising doctor, ANY of the AVAILABLE study drugs are contra-indicated (eg, because of patient characteristics, chronic liver or heart disease, or some concurrent medication).
研究者
相似试验
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-LVWorld Health Organization100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19EUCTR2020-001366-11-IEWorld Health Organisation100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19EUCTR2020-001366-11-ESFIB-HCSC100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 inhospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-ROMinistry of Health100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19MedDRA version: 23.0Level: HLTClassification code 10084510Term: Coronavirus infectionsSystem Organ Class: 100000004862EUCTR2020-001366-11-PTAICIB100,000